The Claim
The CCDS Variant Curation Expert Panel (VCEP) is one of the first ClinGen panels to develop gene-specific ACMG/AMP classification guidelines for an X-linked disorder, specifically SLC6A8-related cerebral creatine deficiency syndrome, with customized criteria for de novo occurrence, segregation analysis, and case counting.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A group of experts was one of the first to make special rules for classifying gene changes in a rare brain disorder caused by a faulty gene on the X chromosome, helping doctors better understand how these changes are linked to the disease.
See the scientific wording
The CCDS VCEP is among the first ClinGen panels to develop gene-specific ACMG/AMP classification guidelines for an X-linked disorder, specifically for SLC6A8-related cerebral creatine deficiency syndrome, incorporating tailored criteria for de novo occurrence, segregation, and case counting.
What the research says
1 studyThe study shows that a group of experts created special rules to classify gene changes in a rare brain disorder linked to the X chromosome, which supports the claim that they were among the first to do this for this specific condition.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.